Molecular basis of the VHL hereditary cancer syndrome
The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.
Abstract
The von Hippel-Lindau hereditary cancer syndrome was first described about 100 years ago. The unusual clinical features of this disorder predicted a role for the von Hippel-Lindau gene (VHL) in the oxygen-sensing pathway. Indeed, recent studies of this gene have helped to decipher how cells sense changes in oxygen availability, and have revealed a previously unappreciated role of prolyl hydroxylation in intracellular signalling. These studies, in turn, are laying the foundation for the treatment of a diverse set of disorders, including cancer, myocardial infarction and stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the PHDs utilize ␣-ketoglutarate as a cosubstrate and require ferrous iron (Fe 2ϩ ) and ascorbate as cofactors (Kaelin, 2002;Schofield and Zhang, 1999).”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The interaction of pVHL with HIF-α is governed by the enzymatic hydroxylation of conserved proline residues that are located within highly conserved, peptidic, pVHL-binding domains within the HIF-α subunit”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citation
Research works printed but not linked: 5
- Collins, E. T. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. UK 14, 141–149 (1894).
- Clifford, S., Prowse, A., Affara, N., Buys, C. & Maher, E. Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200–209 (1998). · DOI · Paper page
- Gallou, C. et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999). · DOI
- Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian HIF prolyl hydroxylase. Proc. Natl Acad. Sci. USA (in the press).
- Aiello, L. et al. Rapid and durable recovery of visual function in a patient with von Hippel–Lindau syndrome and optic nerve head hemangioma following systemic treatment with the VEGF receptor inhibitor SU5416. Ophthalmology (in the press).
Cited by
Items 801–864 of 864
HEREDITARY AND GENETIC CONDITIONS AND MALFORMATIONS
Caplan, L. R., & Bogousslavsky, J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.017
Modulation of Protein Stability: Targeting the VHL Pathway
Kim, W. Y., & Kaelin, W. G. (2009) · Springer eBooks · doi:10.1007/978-0-387-69147-3_4
Self-citationSomatic Alterations in Prostate Cancer Progression
Porkka, K. P., & Visakorpi, T. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_15
Deubiquitinating Enzymes, Cell Proliferation, and Cancer
Baker, R. T. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch9b
Ariss, M. M., Ragge, N., Moodley, M., & Traboulsi, E. I. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0046
EGFR and HER2: Relevance in Renal Cell Carcinoma
Jonasch, E., & Walker, C. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_16
Kongkham, P. N., & Rutka, J. T. (2010) · Springer eBooks · doi:10.1007/978-3-642-02874-8_21
Kongkham, P. N., & Rutka, J. T. (2006) · Springer eBooks · doi:10.1007/3-540-31260-9_20
Faculty Opinions recommendation of Regulation of ubiquitin ligase dynamics by the nucleolus.
Maler, L. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1028010.335919
Bassingthwaighte, J. B. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.716647808.792052808
Navaratnam, J., Eide, N. A., Bærland, T. P., Rekstad, B. L., & Nilsen, T. (2022) · Journal of Ophthalmology and Advance Research · doi:10.46889/joar.2022.3103
Mole, D. R., & Ratcliffe, P. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00011-8 · Cited by 1
The Role of Hepatocyte Growth Factor Pathway Signaling in Renal Cell Carcinoma
Cecchi, F., Lee, Y. H., Peruzzi, B., Lattouf, J., & Bottaro, D. P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_15
Pathogen-Endocrine System Interactions
Bolander, F. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012111232-5/50016-6
The Hypoxic Response and Aging
Leiser, S. F., Miller, H. A., & Kaeberlein, M. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00004-6
Giordano, M., Arráez, C., & Rocco, C. D. (2020) · Springer eBooks · doi:10.1007/978-3-319-72168-2_46
Stolle, C. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-87374-9_23
Harbour, J. W., & Chao, D. L. (2013) · Springer eBooks · doi:10.1007/978-3-642-40489-4_6
Reviews and comment from the nature publishing group
(2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd908
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Bluebond, R., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143.pub2
Liu, Y. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.6236
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2023) · doi:10.1158/0008-5472.c.6493911.v1
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2023) · doi:10.1158/0008-5472.c.6493911
Roberts, A. M., Watson, I. R., Evans, A. J., Foster, D. A., Irwin, M. S., & Ohh, M. (2023) · doi:10.1158/0008-5472.c.6500499
Tumor Suppressor Gene VHL, Mechanism and Related Therapy
Shi, D. (2023) · MedScien · doi:10.61173/tgh4jv76
Kumar, V., Sabaté-Cadenas, X., Soni, I., Stern, E., Vias, C., Ginsberg, D., Mateo, C. R., Pulido, R., Dodel, M., Mardakheh, F. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.23.563579
Ding, X., Liang, T., Li, B., Liang, B., Li, J., Chen, S., Li, J., Wang, S., Wang, S., Cao, Y., et al. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2286210
Salgueiro, W. G., Esmaillie, R., Bohl, K., Statzer, C., Bharill, P., Bargfrede, S., Chokkalingam, M., Neutzer, M., Ignarski, M., Benzing, T. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.22.581513
Teisseire, M., Sahu, U., Parola, J., Tsai, M.-C., Vial, V., Durivault, J., Grépin, R., Cormerais, Y., Pagès, G., Ben‐Sahra, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.22.586287
The development of innovative therapeutic drugs targeting hypoxia responses
Yoshikawa, K., Hagimoto, H., & Nakamura, E. (2024) · Folia Pharmacologica Japonica · doi:10.1254/fpj.23090
Nathanson, K. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00019-1
Familial and Syndrome-Related Pheochromocytoma and Paraganglioma
de Krijger, R. R., Tischler, A. S., Asa, S. L., Lack, E. E., & Volante, M. (2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-10
Helmi, H. A., Alsaad, R., Alkhiary, H. T., & Alkatan, H. M. (2025) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2025.110867
Grüner, T. F., Ramachandran, H., Thomas, A. C., Hildebrandt, B., Gläsker, S., Dobner, J., & Rossi, A. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103748
Ocular Manifestations of Neuro-Oculo-Cutaneous Syndromes
Moodley, M., Aronow, M. E., Robles-Lopez, K., & Utz, V. M. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197659403.003.0050 · Cited by 1
Gadewal, N., Karn, V., Talati, V. P., & Bastikar, V. A. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00587-1 · Cited by 1
The hypoxic response extends lifespan through a bioaminergic and peptidergic neural circuitPreprint
Kitto, E. S., Huang, S., Bhandari, M., Tian, C., Cox, R. L., Beydoun, S., Wang, E. Q., Shave, D., Miller, H. A., Easow, S. A., et al. (2025) · eLife · doi:10.7554/elife.107651.1
Neurogenetic tumor syndromes: The current landscape of workup and treatment
Lukas, R. V., Cannon, A. D., Chittiboina, P., Vasudevan, H. N., Blakeley, J. O., & Hirbe, A. C. (2025) · Neuro-Oncology Practice · doi:10.1093/nop/npaf089 · Cited by 2
Feilen, T., Andreev, G., Rogg, M., Cosenza‐Contreras, M., Pinter, N., Zirngibl, M., Elsässer, A., Huesgen, P. F., Grabbert, M. T., Schell, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.23.683844
A Family case of von Hippel-Lindau syndrome
Atanesyan, R. A., Klimov, L., Вдовина, Т. М., Saneeva, G., Андреева, Е. И., & Gasparyan, I. K. (2025) · Problems of Endocrinology · doi:10.14341/probl13510 · Cited by 1
Regional and Sexual Dimorphism in Murine Skeletal Responses to Osteocytic HIF Pathway Modulation
Mendoza, S. V., Murugesh, D. K., Osipov, B., Christiansen, B., Loots, G. G., Yellowley, C. E., & Genetos, D. C. (2025) · Journal of Orthopaedic Research® · doi:10.1002/jor.70096 · Cited by 1
Nielsen, S. M. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Hereditary brain tumor associated with vertigo and equilibrium disturbance
Sakurai, A. (2014) · Equilibrium Research · doi:10.3757/jser.73.477
Panarsky, R., Crooks, D. R., Lane, A. N., Yang, Y., Cassel, T., Fan, T. W. M., Linehan, W. M., & Moscow, J. A. (2020) · Figshare · doi:10.6084/m9.figshare.12752123
Hereditary Tumor Syndromes of the Pancreas
Zhang, X., Zhang, Y., Zhu, M., & Zhang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-4993-1_16
Gasendo, J. G., Chan, S., Patel, H. V., Smith, A. E., Kessler, L. V., Liu, Y. A., Mitra, A., Burrows, F. J., & Malik, S. (2026) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0449 · Cited by 1
Hemangioblastomas of the Spinal Cord
Damante, M. A., & Lonser, R. R. (2026) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2026.03.002
Zhuang, X., Zhou, Y., Gao, F., Xuan, Y., Wang, M., Chang, Q., Huang, X., Xu, G., & Liu, W. D. (2026) · Eye and Vision · doi:10.1186/s40662-026-00489-x
Unusual cystic presentation of pheochromocytoma in a case of suspected von Hippel–Lindau disease
Bisht, S., Raj, G., & Agarwal, A. (2026) · Radiology Case Reports · doi:10.1016/j.radcr.2026.06.005
Zhang, W., Yang, Y., Ren, C., Jiang, X., & Lu, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1885470
Rare genetic endocrine tumor syndromes: VHL, NF1, TSC, and Carney complex
Vrachnis, D. N., & Stratakis, C. A. (2026) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2026.102159
Renal cell carcinoma: molecular understanding and therapeutic development
Hou, T., Hua, X., Wei Min, N. I., Yan, P., Inuzuka, H., & Wei, W. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01857-9
Progress on Mechanisms of Therapeutic Potential of Oxygen Delivery in Brain Disorders
Lv, J., & Guo, D. (2026) · Neuroendocrinology · doi:10.1159/nen/advag002
The hypoxic response extends lifespan through a bioaminergic and peptidergic neural circuitPreprint
Kitto, E. S., Huang, S., Bhandari, M., Tian, C., Cox, R. L., Beydoun, S., Wang, E., Shave, D., Miller, H. A., Easow, S. A., et al. (2026) · eLife · doi:10.7554/elife.107651.2
Glutamine Metabolism in Health and Diseases
Ding, Y., Tong, F., Zeng, J., & Cui, C. (2026) · MedComm · doi:10.1002/mco2.71035 · Cited by 2
Doria-Medina, R., Neidert, N., Hohenhaus, M., Steiert, C., Rhein, K., Ganner, A., Hohenhaus, R., Beck, J., & Klingler, J. (2026) · Brain and Spine · doi:10.1016/j.bas.2026.107479
Doria-Medina, R., Neidert, N. N., Hohenhaus, M., Rau, A., Duman, İ. E., Elsheikh, S., Taschner, C. A., Beck, J., Klingler, J., & Steiert, C. (2026) · Brain and Spine · doi:10.1016/j.bas.2026.107475
Zhang, C., Gao, Y., Yang, T., Feng, Z., 马春梅, Lv, L., Yang, F., & Lv, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1974418
Navigating hypoxia in tissue engineering: From biological mechanisms to therapeutic strategies
Vieira, B., Cerqueira, A., Nunes, P. J., & Mano, J. F. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.10.041
Molecular Pathology of Pancreatic Neuroendocrine Neoplasms
Furlan, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-17235-4_20
The Dual Role of HIF Hydroxylase PHD3 in Cancer Cell Survival
Rantanen, K. (2012) · UTUPub (University of Turku)
Mise au point sur le traitement médical du cancer du rein métastatique
Mellas, N., Mellas, S., Masbah, O., & Errihani, H. H. (2009) · Journal africain du cancer / African Journal of Cancer · doi:10.1007/s12558-009-0029-9
Metadata
- Authors
- Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- ORCID
- Kaelin, William G.
- Venue
- Nature Reviews Cancer
- Published
- 2002-09
- Volume
- 2
- Issue
- 9
- Pages
- 673-682
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2093776019
- Semantic Scholar
- 6b13bcf0623256d5dceb071144a84d45b84f9a99
- Cited by
- 865
- References
- 146
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 25 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 32 · 2018: 28 · 2017: 22 · 2016: 27 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 46
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- von Hippel-Lindau disease, VHL gene, hereditary cancer, oxygen sensing, prolyl hydroxylation, hypoxia signaling, tumour suppressor, cancer therapy
- MeSH terms
- Animals, von Hippel-Lindau Disease, Humans, Ligases, Neoplasms, Gene Expression Regulation, Neoplastic, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.